ArticleCancer management and research2021

Silencing of circHIPK3 Sensitizes Paclitaxel-Resistant Breast Cancer Cells to Chemotherapy by Regulating HK2 Through Targeting miR-1286.

Jun Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.